These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
71 related articles for article (PubMed ID: 1781121)
1. [Experience in the use of streptodecase in the treatment of intraocular hemorrhage]. Amirova EKh; Dubileĭ OV Vestn Oftalmol; 1991; 107(6):34-6. PubMed ID: 1781121 [TBL] [Abstract][Full Text] [Related]
2. [Immobilized streptokinase (streptodecase) in the treatment of traumatic intra-ocular hemorrhage]. Gundorova RA; Romashchenko AD Vopr Med Khim; 1985; 31(4):47-51. PubMed ID: 4049786 [TBL] [Abstract][Full Text] [Related]
3. [Prospects for treating intraocular traumatic hemorrhage using a new fibrinolytic hemase]. Stepanov AV; Bolkvadze ER; Belogurov AA; Tovarova II Vestn Oftalmol; 2002; 118(5):25-7. PubMed ID: 12532741 [TBL] [Abstract][Full Text] [Related]
4. [The efficacy of treating patients with intraocular hemorrhages with emoxypin]. Mokhammad I; Cherkasov IS Oftalmol Zh; 1990; (1):29-30. PubMed ID: 2280919 [TBL] [Abstract][Full Text] [Related]
5. An analysis of risk for secondary hemorrhage in traumatic hyphema. Rahmani B; Jahadi HR; Rajaeefard A Ophthalmology; 1999 Feb; 106(2):380-5. PubMed ID: 9951494 [TBL] [Abstract][Full Text] [Related]
6. [Streptodecase magnetophoresis in the Polius-3 treatment of post-traumatic intraocular bleeding]. Zobina LV; Malkov IuV Med Tekh; 1996; (6):41-2. PubMed ID: 9053713 [TBL] [Abstract][Full Text] [Related]
7. [New class of drugs for treatment of eye vascular diseases]. Travkin AG; Romashchenko AD Vestn Oftalmol; 1997; 113(6):35-6. PubMed ID: 9484000 [TBL] [Abstract][Full Text] [Related]
11. [Immobilized streptokinase (streptodecase) in the treatment of intraocular hemorrhages]. Chazov EI; Gundorova RA; Romashchenko AD; Makarova VP; Mazaev AV Vestn Oftalmol; 1982; (4):61-4. PubMed ID: 7135738 [No Abstract] [Full Text] [Related]
12. [Pavlyuk--antioxidant "Gistochrom" in the complex treatment of intraocular hemorrhages in children]. Guseva MR; Chinenov IM; Shirshov MV; Gorbunova ED; Pavliuk AIu Vestn Oftalmol; 2005; 121(2):24-8. PubMed ID: 15881152 [TBL] [Abstract][Full Text] [Related]
13. [Clinical rationale for the efficiency of using the domestic antioxidant agent Histochrome]. Guseva MR; Beslaneeva MB Vestn Oftalmol; 2010; 126(3):37-40. PubMed ID: 20608199 [TBL] [Abstract][Full Text] [Related]
14. [Clinical effectiveness and administration of streptodecase in patients with acute myocardial infarction]. Barbakar' NG; Mazaev AV Ter Arkh; 1984; 56(11):19-23. PubMed ID: 6395428 [TBL] [Abstract][Full Text] [Related]